Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

It's likely all shareholders want as much information as possible, but it's not like Leo hasn't been communicating the past year. I find it's best to read SEC filings and press releases.

Follow this link for all SEC filings: https://www.sec.gov/cgi-bin/browse-edgar?company=innovation+pharmaceuticals&owner=exclude&action=getcompany

Follow this link for all press releases: https://www.ipharminc.com/press-release


Following are eight press releases from the past four months.

https://www.ipharminc.com/press-release/2020/8/26/dr-william-f-degrado-a-discoverer-of-brilacidin-joins-innovation-pharmaceuticals-as-scientific-advisor August 26, 2020

https://www.ipharminc.com/press-release/2020/9/8/innovation-pharmaceuticals-announces-publication-of-independent-research-on-kevetrin-the-companys-p53-drug-candidate-in-oncology-reports September 8, 2020

https://www.ipharminc.com/press-release/2020/9/15/laboratory-testing-of-brilacidin-for-covid-19-in-combination-with-remdesivir-reduces-viral-load-by-nearly-100-percent September 15, 2020

https://www.ipharminc.com/press-release/2020/10/2/innovation-pharmaceuticals-announces-pre-ind-meeting-request-granted-by-fda-for-the-study-of-brilacidin-for-the-treatment-of-covid-19 October 2, 2020

https://www.ipharminc.com/press-release/2020/10/30/innovation-pharmaceuticals-and-george-mason-university-announce-public-release-of-laboratory-testing-results-demonstrating-brilacidins-covid-19-treatment-potential October 30, 2020

https://www.ipharminc.com/press-release/2020/11/2/innovation-pharmaceuticals-receives-pre-ind-response-from-fda-on-covid-19-trial November 2, 2020

https://www.ipharminc.com/press-release/2020/11/15/innovation-pharmaceuticals-announces-overseas-regulatory-filing-submitted-for-covid-19-clinical-study November 16, 2020

https://www.ipharminc.com/press-release/2020/11/30/innovation-pharmaceuticals-covid-19-clinical-trial-to-support-additional-development-of-brilacidin-as-a-pan-coronavirus-therapeutic November 30, 2020

https://www.ipharminc.com/press-release/2020/12/21/fda-grants-ind-approval-for-phase-2-clinical-trial-of-innovation-pharmaceuticals-brilacidin-for-treating-covid-19 December 21, 2020

https://www.ipharminc.com/press-release/2021/1/14/innovation-pharmaceuticals-brilacidin-for-the-treatment-of-covid-19-receives-fda-fast-track-designation January 14, 2021

https://www.ipharminc.com/press-release/2021/1/29/innovation-pharmaceuticals-phase-2-clinical-trial-of-brilacidin-for-treating-covid-19-scheduled-to-begin-next-week January 29, 2021



Edit to add that I don't read anything into company silence on anything due to the political climate having changed dramatically since the start of Covid. I'm just waiting on trial results.









Message in reply to:

We learned of Russia from Leo’s comment in the NT late filing for the 10-Q. No money is due from Alphasigma until the product is marketable.

Clearly more info from Leo would be appreciated by all.